Robinhood Markets, Inc.’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
Other funds holding MLTX
Robinhood Markets, Inc.'s MLTX Position: Q3 2026 in Review
Robinhood Markets, Inc. opened a new position in MoonLake Immunotherapeutics (MLTX) in Q3 2026: 24 shares worth $278. The stake represents ﹤0.01% of the portfolio and ranks #947 among its holdings.
169 funds tracked by Wall St. Rank hold MLTX as of Q3 2026.
- Robinhood Markets, Inc. held 24 shares of MoonLake Immunotherapeutics worth $278 as of Q3 2026.
- MoonLake Immunotherapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
- MoonLake Immunotherapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #947 holding.
- 169 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2026.
Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.